Scientific Review of FDA's Draft Risk Profile on Spices

ASTA issued a letter to the U.S. House of Representatives in June 2009 regarding concerns with several provisions in the Food Safety Enhancement Act of 2009, including traceability and the country of origin requirement in the bill.

ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.